Table: Immuno Biological Lab -Q1 group results

Immuno-Biological Laboratories

05/08/2022 07:30

Aug 5 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2022        Jun 30, 2021      Mar 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            156 mln             125 mln           775 mln    
                 (+25.0 pct)         (+7.3 pct)        (+19.7 pct)  
  Operating      loss 14 mln         loss 73 mln          3 mln     
  Recurring      loss 54 mln        loss 101 mln       loss 95 mln  
  Net            loss 58 mln        loss 110 mln      loss 120 mln  
  EPS           loss 6.32 yen      loss 11.89 yen    loss 12.88 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T